Randomized study to compare Paclitaxel/Topotecan vs. Cisplatin/Topotecan in patients with recurrent cervical cancer - AGO-Cervix-1 study

被引：0
|
作者：
Thiel, F. C. [1 ]
Hilpert, F. [2 ]
Rein, D. [3 ]
Liebrich, C. [4 ]
Fasching, P. A. [5 ]
Beckmann, M. W. [5 ]
机构：
[1] Univ Frauenklin Erlangen, Erlangen, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Kiel, Germany
[3] Univ Frauenklin, Dusseldorf, Germany
[4] Klinikum Stadt Wolfsburg, Frauenklin, Wolfsburg, Germany
[5] Univ Klinikums Erlangen, Frauenklin, Erlangen, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷
关键词：
cervical cancer; paclitaxel; recurrent; topotecan;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [31] Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
    Andreopoulou, Eleni
    Chen, Thomas
    Liebes, Leonard
    Curtin, John
    Blank, Stephanie
    Wallach, Robert
    Hochster, Howard
    Muggia, Franco
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 457 - 463
  • [32] Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer
    Eleni Andreopoulou
    Thomas Chen
    Leonard Liebes
    John Curtin
    Stephanie Blank
    Robert Wallach
    Howard Hochster
    Franco Muggia
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 457 - 463
  • [33] COMBINATION THERAPY WITH TOPOTECAN, PACLITAXEL, AND BEVACIZUMAB IMPROVES PROGRESSION-FREE SURVIVAL IN PATIENTS WITH RECURRENT HIGH-GRADE NEUROENDOCRINE CARCINOMA OF THE CERVIX: A NECTUR STUDY
    Frumovitz, Michael
    Chisholm, Gary
    Jhingran, Anuja
    Ramalingam, Preetha
    Flores-Legarreta, Alejandra
    Bhosale, Priya
    Gonzales, Naomi
    Hillman, Tyler
    Salvo, Gloria
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A6 - A6
  • [34] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    A E Guppy
    A E Nelstrop
    T Foster
    R Agarwal
    M J Seckl
    G J S Rustin
    British Journal of Cancer, 2004, 90 : 810 - 814
  • [35] Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
    Frumovitz, Michael
    Chisholm, Gary B.
    Jhingran, Anuja
    Ramalingam, Preetha
    Flores-Legarreta, Alejandra
    Bhosale, Priya
    Gonzales, Naomi R.
    Hillman, R. Tyler
    Salvo, Gloria
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (04) : 445.e1 - 445.e8
  • [36] PHASE-I STUDY OF PACLITAXEL AND TOPOTECAN IN PATIENTS WITH ADVANCED TUMORS - A CANCER AND LEUKEMIA GROUP-B STUDY
    LILENBAUM, RC
    RATAIN, MJ
    MILLER, AA
    HARGIS, JB
    HOLLIS, DR
    ROSNER, GL
    OBRIEN, SM
    BREWSTER, L
    GREEN, MR
    SCHILSKY, RL
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2230 - 2237
  • [37] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
    Guppy, AE
    Nelstrop, AE
    Foster, T
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2004, 90 (04) : 810 - 814
  • [38] Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group study 0942
    Wells, RJ
    Reid, JM
    Ames, MM
    Mares, WL
    Krailo, MD
    Seibel, NL
    Mosher, R
    Reaman, GH
    Wiersma, SR
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 89 - 93
  • [39] A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer
    Gatcliffe, Troy A.
    Tewari, Krishnansu S.
    Shah, Amy
    Brewster, Wendy R.
    Burger, Robert A.
    Kuo, Jeffrey V.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (01) : 85 - 89
  • [40] Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian trials in ovarian cancer (MITO-1) randomized study
    De Placido, S
    Scambia, G
    Di Vagno, G
    Naglieri, E
    Lombardi, AV
    Biamonte, R
    Marinaccio, M
    Carteni, G
    Manzione, L
    Febbraro, A
    de Matteis, A
    Gasparini, G
    Valerio, MR
    Danese, S
    Perrone, F
    Lauria, R
    De Laurentiis, M
    Greggi, S
    Gallo, C
    Pignata, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2635 - 2642
12345